News tagged with cervarix
Cervarix
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).
Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases. These types also cause some other genital cancers and some oropharyngeal cancers. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials. Cervarix also contains AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time.
Cervarix is manufactured by GlaxoSmithKline. An alternative product, from Merck & Co., is known as Gardasil.
For more information about Cervarix, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
FDA says Glaxo vaccine blocks cancer-causing virus
(AP) -- A vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer, the Food and Drug Administration said Friday.
Sep 04, 2009 |
4 / 5 (1) |
1
British girl dies after cervical cancer vaccine jab
British drug giant GlaxoSmithKline said Tuesday it was working with health authorities here probing the death of a schoolgirl following a cervical cancer vaccination.
Medicine & Health / Medications
Sep 29, 2009 |
1 / 5 (2) |
3
UK official: Vaccine unlikely to have caused death
(AP) -- A British health official said Tuesday that the sudden death of 14-year-old girl was very unlikely to have been caused by the vaccine she was given hours before she died.
Medicine & Health / Medications
Sep 29, 2009 |
3 / 5 (2) |
0
Survey of American women finds STD vaccine viewed positively
Cost but not convenience plays a significant role in attitudes about vaccination for common human papillomaviruses for women over the age of 26, according to the authors of a recent article in the journal Sexual Health.
Aug 24, 2010 |
not rated yet |
0
UK coroner says tumor likely killed girl
(AP) -- A British coroner says a girl who died after receiving a vaccine against cervical cancer was likely killed by a tumor.
Oct 01, 2009 |
2.3 / 5 (3) |
0
WHO approves cervical cancer vaccine Cervarix
(AP) -- The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries ...
Jul 09, 2009 |
1 / 5 (1) |
0
